Back

Notification report


Full notification file


General information

Notification Number
B/BE/03/B3

Member State to which the notification was sent
Belgium

Date of acknowledgement from the Member State Competent Authority
30/07/2003

Title of the Project
Study TG1024.01: "Phase I multicentre study of TG1024 (Adenovirus interleukin 2) in patients with metastatic melanoma or other advanced solid tumor cancers"

Proposed period of release:
01/05/2004 to 31/05/2005

Name of the Institute(s) or Company(ies)
Transgene S.A., ;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Non replicative, recombinant adenovirus of type 5 (group C) deleted in regions E1 and E3, named ADTG13383.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Adenovirus human serotype 5 (Ad5)MastadenovirusHuman adenovirus type 5subgroup C

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known